相关实验视频

Updated: Jun 21, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

加强对耐药结核病的诊断,使用基于NGS的方法和生物信息学管道用于印度的数据分析

Vaibhav Kumar Tamrakar^1,2, Nitish Singh Parihar^1,2, Jyothi Bhat³

¹ICMR - National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh India.

Indian journal of microbiology

|July 16, 2024

概括

印度的耐药结核病 (DR-TB) 需要先进的诊断. 使用TBProfiler和Mykrobe等生物信息管道的下一代测序 (NGS) 提供了快速,准确的DR-TB检测,尽管存在实施挑战,但改善了患者的治疗结果.

科学领域:

微生物学微生物学
基因组学就是基因组学.
公共卫生公共卫生

背景情况:

耐药结核病 (DR-TB) 在印度构成了重大公共卫生挑战,新发病例和先前治疗病例的流行率很高.
传统的DR-TB诊断方法是缓慢和有限的,阻碍了及时治疗和疾病控制.
下一代测序 (NGS) 为检测抗性突变提供了一个快速而准确的替代方案.

研究的目的:

评估基于NGS的方法和生物信息学管道在印度诊断DR-TB的潜力.
要突出像TBProfiler和Mykrobe这样的管道在分析DR-TB的NGS数据中的作用.
讨论这些技术对改善患者结果和指导治疗决策的影响.

主要方法:

使用下一代测序 (NGS) 进行Mycobacterium结核病的综合遗传分析.
使用生物信息管道 (TBProfiler,Mykrobe) 来处理NGS数据.
分析数据以检测耐药性突变和预测药物易感性.

主要成果:

基于NGS的方法可以同时快速准确地识别多个抗性突变.
生物信息学管道有效地分析大型NGS数据集,以预测药物易感性.
这些方法有助于为个性化DR-TB治疗做出明智的临床决策.

结论:

在印度,NGS和相关的生物信息管道代表了对DR-TB诊断的有希望的进步.
通过这些技术早期发现耐药性,可以显著改善患者的治疗结果.
广泛采用面临挑战,包括成本,基础设施和训练有素的人员,需要有针对性的干预.

关键词:

生物信息学工具生物信息学工具诊断诊断诊断诊断诊断耐药结核病的治疗方法这是下一代测序.结核病是一种疾病.

更多相关视频

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...